Comparison of an antibody model with an X-ray structure: The variable fragment of BR96

Proteins: Structure, Function and Genetics

Volumn 24, Issue 2, 1996, Pages 152-157

  Bajorath, Jürgen ^a   Sheriff, Steven ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b Dept of Macromolec Crystallography ^*  (United States)

Author keywords

antibody modeling; antibody X ray crystallography; model evaluation; prediction accuracy; protein structure prediction; structure comparison

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; CARBOHYDRATE; DOXORUBICIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BR96; UNCLASSIFIED DRUG;

ANTIBODY STRUCTURE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR MODEL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; IMMUNOGLOBULIN VARIABLE REGION; LEWIS BLOOD-GROUP SYSTEM; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION;

EID: 0029935478     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(199602)24:2<152::AID-PROT2>3.0.CO;2-L     Document Type: Article

References (26)

1. y-related cell surface antigens. Cancer Res. 50:2183-2190, 1990.
2. Garrigues, J., Anderson, J., Hellström, K.E., Hellström, I. Anti-tumor mAb BR96 blocks cell migration and binds to lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes. J Cell. Biol. 125:129-142, 1994.
3. Willner, D., Trail, P.A., Hofstead, S.J., King, H.D., Lasch, S.J., Braslawsky, G.R., Greenfield, R.S., Kaneko, T., Firestone, R.A. (6-Maleimidocaproyl)hydrazone of doxorubicin - a new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjugate Chem. 4:521-527, 1993.
4. Trail, P.A., Willner, D., Lasch, D.J., Lasch, S.J., Henderson, A.J., Hofstead, S., Casazza, A.M., Firestone, R.A., Hellström, I., Hellström, K.E. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 261:212-215, 1993.
5. Bajorath, J. Three-dimensional model of the BR96 monoclonal antibody variable fragment. Bioconjugate Chem. 5:213-219, 1994.
6. Chang, C.Y., Jeffrey, P.D., Bajorath, J., Hellström, I., Hellström, K.E., Sheriff, S. Crystallization and preliminary X-ray analysis of the monoclonal anti-tumor antibody BR96 and its complex with the Lewis Y determinant. J. Mol. Biol. 235:372-376, 1994.
7. Jeffrey, P.D., Bajorath, J., Chang, C.Y., Yelton, D., Hellström, I., Hellström, K.E., Sheriff, S. The X-ray structure of an anti-tumour antibody in complex with antigen. Nature Struct. Biol. 2:466-471, 1995.
8. Chothia, C., Lesk, A.M., Levitt, M., Amit, A.G., Mariuzza, R.A., Phillips, S.E.V., Poljak, R. The predicted structure of imnmnoglobulin D1.3 and its comparison with the crystal structure. Science 233:755-758, 1986.
9. Chothia, C., Lesk, A.M. Canonical structures of the hypervariable regions of immunoglobulins. J. Mol. Biol. 196: 901-971, 1987.
10. Chothia, C., Lesk, A.M., Tramontano, A., Levitt, M., Smith-Gill, S.J., Air, G., Sheriff, S., Padlan, E.A., Davies, D., Tulip, W.R., Colman, P.M., Spinelli, S., Alzari, P.M., Poljak, R.J. The conformations of immunoglobulin hypervariable regions. Nature (London) 342:877-883, 1989.
11. HER2 antibody 4D5 and comparison with molecular modeling. J. Mol. Biol. 229:969-995, 1993.
12. Essen, L.-O., Skerra, A. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model. J. Mol. Biol. 238:226-244, 1994.
13. Bajorath, J., Stenkamp, R., Aruffo, A. Knowledge-based model building of proteins: Concepts and examples. Protein Sci. 2:1798-1810, 1993.
14. Bruccoleri, R.E., Karplus, M. Prediction of folding of short polypeptide segments by uniform conformational sampling. Biopolymers 26:137-168, 1987
15. Bruccoleri, R E., Haber, E., Novotny, J. Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature (London) 335:483-485, 1989.
16. Herron, J.N., Terry, A.H., Johnston, S., He, X.-M., Guddat, L.W., Voss, E.W., Jr., Edmundson, A.B. High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: Effects of solvent on structure and antigen-binding affinity. Biophys. J. 67:2167-2183, 1994.
17. Rini, J.M., Schulze-Gahmen, U., Wilson, I.A. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255:959-965, 1992.
18. Novotny, J., Sharp, K. Electrostatic fields in antibodies and antibody/antigen complexes. Prog. Biophys. Mol. Biol. 58:203-224, 1992.
19. Steipe, B., Plückthun, A., Huber, R. Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant. J. Mol. Biol. 225:739-753, 1992.
20. Stanfield, R.L., Takimoto-Kamimura, M., Rini, J.M., Profy, A.T., Wilson, I.A. Major antigen-induced domain rearrangements in an antibody. Structure 1:83-93, 1993.
21. Wilson, I.A., Stanfield, R.L. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4:857-867, 1994.
22. Bajorath, J., Harris, L., Novotny, J. Conformational similarity and systematic displacement of complementarity determining region loops in high resolution antibody X-ray structures. J. Biol. Chem. 270:22081-22084, 1995.
23. Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman, K.S., Foeller, C. "Sequences of Proteins of Immunological Interest," 5th ed. Bethesda, MD: National Institutes of Health, 1991.
24. Davies, D.R., Padlan, E A. Twisting into shape. Curr. Biol. 2:254-256, 1992.
25. Wilson, I.A., Stanfield, R.L Antibody-antigen interactions. Curr. Opin. Struct. Biol. 3:113-118, 1993
26. Totrov, M., Abagyan, R. Detailed ab initio prediction of lysozyme-antibody complex with 1.6 Å accuracy. Nature Struct. Biol. 1:259-263, 1994.